Advancing Powder-Based Nasal Products: Leveraging Stability & Rapid Absorption to Unlock Next-Generation Intranasal Therapies
9:00 am - Thursday 4th February 2027
- Explore how powder formulations can overcome stability limitations associated with traditional liquid products while simplifying storage, transportation, and long-term product performance
- Understand how formulation and device design influence deposition, absorption, and pharmacodynamic performance, including lessons learned from clinical development
- Learn how developers are overcoming regulatory, manufacturing, and product development challenges when advancing powder-based intranasal products toward commercialization
